SANUWAVE Reports Third Quarter Financial Results And Provides A Business Update

ALPHARETTA, Ga., Nov. 12, 2015 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB:SNWV), today reported financial results for the three and nine months ended September 30, 2015 and provided a business update. The Company will host a conference call tomorrow, Friday, November 13, 2015, at 11:00 a.m. Eastern Time.

Highlights of the third quarter and recent weeks:

* Top Line Data Released for dermaPACE® Clinical Trial Shows Success at 20 Week Endpoint: As previously announced, success for the pre-defined primary endpoint comparing the rate of complete wound closure in patients at 12 weeks occurring between the active, dermaPACE arm and the inactive Sham was not achieved under the Bayesian statistical design. However, as expected, in a secondary analysis using the same endpoint, but analyzed using the occurrence of complete wound closures at later times in the study, particularly at 20 weeks, the dermaPACE arm demonstrated success over the Sham arm with a posterior probability of 0.994.
Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC